Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-chloroprocaine
2. Chlor-procaine
3. Chloroprocaine
4. Nesacaine
5. Nesacaine Mpf
1. 3858-89-7
2. Chloroprocaine Hcl
3. Chloroprocaine (hydrochloride)
4. 2-chloroprocaine Hydrochloride
5. Nesacaine
6. Chebi:3637
7. 2-chloroprocaine;halestyn; Piocaine
8. 2-diethylaminoethyl 4-amino-2-chlorobenzoate Hydrochloride
9. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate;hydrochloride
10. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Monohydrochloride
11. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Hydrochloride
12. Lt7z1yw11h
13. Chloroprocaine Hydrochloride (usp)
14. 4-amino-2-chlorobenzoic Acid 2-(diethylamino)ethyl Ester Hydrochloride
15. Benzoic Acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl Ester, Monohydrochloride
16. Ncgc00183273-01
17. Clorotekal (tn)
18. Nesacaine (tn)
19. Clorotekal
20. Chloroprocainhydrochlorid
21. Chloroprocainehydrochloride
22. Chembl944
23. Chlorprocaine Chloride
24. Dsstox_cid_28521
25. Dsstox_rid_82793
26. Dsstox_gsid_48595
27. Schembl24096
28. Dtxsid6048595
29. Hy-b1604
30. Tox21_112925
31. S4284
32. Ccg-267543
33. Chloroprocaine Hydrochloride [mi]
34. Cas-3858-89-7
35. Chloroprocaine Hydrochloride [mart.]
36. Chloroprocaine Hydrochloride [vandf]
37. Chloroprocaine Hydrochloride [usp-rs]
38. Chloroprocaine Hydrochloride [who-dd]
39. Cs-0013536
40. Sw220257-1
41. A14260
42. D00732
43. 858c897
44. A912305
45. Chloroprocaine Hydrochloride [orange Book]
46. Chloroprocaine Hydrochloride [usp Monograph]
47. W-106476
48. Q27068150
49. Chloroprocaine Hydrochloride 1000 Microg/ml In Methanol
50. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Hcl
51. Benzoic Acid,4-amino-2-chloro-,2-(diethylamino)ethyl Ester
52. [2-(4-amino-2-chloro-benzoyloxy)-ethyl]-diethyl-ammonium; Chloride
53. 4-amino-2-chlorobenzoicacid2-(diethylamino)ethylesterhydrochloride
54. Benzoic Acid,4-amino-2-chloro-, 2-(diethylamino)ethyl Ester
Molecular Weight | 307.21 g/mol |
---|---|
Molecular Formula | C13H20Cl2N2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 306.0901833 g/mol |
Monoisotopic Mass | 306.0901833 g/mol |
Topological Polar Surface Area | 55.6 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 259 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Chloroprocaine hydrochloride |
Drug Label | Nesacaine and Nesacaine-MPF Injections are sterile non pyrogenic local anesthetics. The active ingredient in Nesacaine and Nesacaine-MPF Injections is chloroprocaine HCL (benzoic acid, 4-amino-2-chloro-2-(diethylamino) ethyl ester, monohydrochloride)... |
Active Ingredient | Chloroprocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2%; 3% |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Chloroprocaine hydrochloride |
Drug Label | Nesacaine and Nesacaine-MPF Injections are sterile non pyrogenic local anesthetics. The active ingredient in Nesacaine and Nesacaine-MPF Injections is chloroprocaine HCL (benzoic acid, 4-amino-2-chloro-2-(diethylamino) ethyl ester, monohydrochloride)... |
Active Ingredient | Chloroprocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2%; 3% |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
Intrathecal anaesthesia
Ocular surface anaesthesia
Epidural anaesthesia
Peripheral nerve block (local anaesthesia by perineural injection)
Intrathecal anaesthesia
Ocular surface anaesthesia
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
GDUFA
DMF Review : Reviewed
Rev. Date : 2021-06-28
Pay. Date : 2021-03-11
DMF Number : 35698
Submission : 2021-04-21
Status : Active
Type : II
NDC Package Code : 66583-0810
Start Marketing Date : 2021-04-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 39268
Submission : 2023-12-19
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-05-24
Pay. Date : 2015-07-27
DMF Number : 8002
Submission : 1989-03-23
Status : Active
Type : II
NDC Package Code : 17381-090
Start Marketing Date : 2010-05-11
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3670
Submission : 1979-12-28
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 23147
Submission : 2009-09-29
Status : Inactive
Type : II
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4282
Submission : 1981-09-10
Status : Inactive
Type : II
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Registration Number : 222MF10113
Registrant's Address : 530 Chokeiji, Takaoka City, Toyama Prefecture
Initial Date of Registration : 2010-03-23
Latest Date of Registration : --
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Hydrochloric Acid NF
Application : Parenteral
Excipient Details : A&C's Hydrochloric Acid NF is used as a low pH neutralizing agent for pharmaceutical applications.
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : NaCl Multi-compendial Low...
Application : Parenteral
Excipient Details : A & C's Sodium Chloride multi-compendial low endotoxin is an excipient meeting USP-NF, EP, BP and JP monographs.
Pharmacopoeia Ref : Multi-compendial
Technical Specs : Low Endotoxin
Ingredient(s) : Sodium Chloride Excipient
Dosage Form : Injectable / Parenteral
Grade : Parenteral
Brand Name : Sodium Chloride USP
Application : Parenteral
Excipient Details : A & C's Sodium Chloride is an excipient meeting the USP monograph.
Market Place
Reply
20 Dec 2024
Reply
16 Apr 2022
Reply
22 Sep 2021
Reply
03 Jan 2020
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Chloroprocaine HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chloroprocaine HCl, including repackagers and relabelers. The FDA regulates Chloroprocaine HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chloroprocaine HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chloroprocaine HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chloroprocaine HCl supplier is an individual or a company that provides Chloroprocaine HCl active pharmaceutical ingredient (API) or Chloroprocaine HCl finished formulations upon request. The Chloroprocaine HCl suppliers may include Chloroprocaine HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Chloroprocaine HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Chloroprocaine HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Chloroprocaine HCl active pharmaceutical ingredient (API) in detail. Different forms of Chloroprocaine HCl DMFs exist exist since differing nations have different regulations, such as Chloroprocaine HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Chloroprocaine HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Chloroprocaine HCl USDMF includes data on Chloroprocaine HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Chloroprocaine HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Chloroprocaine HCl suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Chloroprocaine HCl Drug Master File in Japan (Chloroprocaine HCl JDMF) empowers Chloroprocaine HCl API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Chloroprocaine HCl JDMF during the approval evaluation for pharmaceutical products. At the time of Chloroprocaine HCl JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Chloroprocaine HCl suppliers with JDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Chloroprocaine HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Chloroprocaine HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Chloroprocaine HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Chloroprocaine HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Chloroprocaine HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Chloroprocaine HCl suppliers with NDC on PharmaCompass.
Chloroprocaine HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chloroprocaine HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chloroprocaine HCl GMP manufacturer or Chloroprocaine HCl GMP API supplier for your needs.
A Chloroprocaine HCl CoA (Certificate of Analysis) is a formal document that attests to Chloroprocaine HCl's compliance with Chloroprocaine HCl specifications and serves as a tool for batch-level quality control.
Chloroprocaine HCl CoA mostly includes findings from lab analyses of a specific batch. For each Chloroprocaine HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chloroprocaine HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Chloroprocaine HCl EP), Chloroprocaine HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chloroprocaine HCl USP).
LOOKING FOR A SUPPLIER?